Iveric
Edit

Iveric

http://ophthotech.com/
Last activity: 18.10.2013
Active
Categories: Development
Specializing in the development of novel therapeutics to treat diseases of the eye. (NASDAQ: OPHT)
Mentions
7

Investors 1

Mentions in press and media 7

DateTitleDescription
18.10.2013Health IT deals help push software deals to 12-year high but life science strugglesHere were the biggest health IT deals for the quarter based on data from the MoneyTree Report and Mercom Capital Group’s Healthcare IT report. Evolent Health raised $100 million. EHR provider Practice Fusion raised $70 million. MedSynergies...
16.08.2013Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindnessAfter assembling a whopping $175 million financing deal this spring, Ophthotech has filed paperwork with the SEC to secure up to $85 million more in an initial public offering. So add the New York City-based biotech outfit to the growing li...
29.05.2013Ophthotech Raises $175M in FinancingOphthotech Corporation, a New York-based biopharmaceutical company focusing on discovering, developing and commercializing therapies for the treatment of major ophthalmic diseases, raised $175m in financing. The transaction consists of $125...
29.05.2013Ophthotech Raises $175M NEW YORK, NY, The financing of $175 million consists of $125 million from Novo A/S, in exchange for royalties on Fovista sales. The remaining $50 million is in the form of a Series C preferred stock financing. >> Click here for mor...
15.12.2009Ophthotech Raises $30M in Series B FinancingOphthotech Corp., a Princeton, NJ and New York-based developer of therapies for eye diseases, has closed a $30m Series B financing round. The round was led by Clarus Ventures, with participation from existing investors SV Life Sciences, Nov...
29.10.2007Amgen, Relypsa and the art of the biotech-spinout-startup-restart(UPDATED: See below.) A common dilemma in biotech acquisitions is how to keep a startup’s entrepreneurial management happy and productive when they’ve just been assimilated by the Borg. The answer, often enough, is not to bother, and to let...
-Health IT deals help push software deals to 12-year high but life science strugglesInvestments in electronic health records, tools to help hospitals absorb physician practices and a group working with hospital systems to help them set up their own insurance plans. Those three health IT companies helped drive venture capit...

Reviews 0

Sign up to leave a review

Sign up Log In